These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 963853)

  • 21. High-molecular-weight kininogen and the intrinsic coagulation pathway in patients with de novo acute myocardial infarction.
    Cubedo J; Ramaiola I; Padró T; Martin-Yuste V; Sabate-Tenas M; Badimon L
    Thromb Haemost; 2013 Dec; 110(6):1121-34. PubMed ID: 24096571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly iodinated fibrinogen: a new thrombus-localizing agent.
    Harwig JF; Coleman RE; Harwig SS; Sherman LA; Siegel BA; Welch MJ
    J Nucl Med; 1975 Aug; 16(8):756-63. PubMed ID: 240916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
    Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent.
    Harwig SS; Harwig JF; Coleman RE; Welch MJ
    J Nucl Med; 1976 Jan; 17(1):40-6. PubMed ID: 1244446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical application of Ga-67 DFO-DAS-fibrinogen.
    Itoh K; Tsukamoto E; Saito C; Oguma Y; Furudate M
    Radiat Med; 1987; 5(5):165-9. PubMed ID: 3438485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fibrinogen and coronary heart disease].
    Kienast J
    Versicherungsmedizin; 1995 Aug; 47(4):122-6. PubMed ID: 7676548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Circulation time of 125I-labeled fibrinogen in patients with ischemic heart disease with different types of hyperlipoproteinemia].
    Liusov VA; Belousov IuB; Dudaev VA; Shmushkovich BI
    Kardiologiia; 1976 Apr; 16(4):49-53. PubMed ID: 1030755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory cell content of coronary thrombi is dependent on thrombus age in patients with ST-elevation myocardial infarction.
    Fuijkschot WW; Groothuizen WE; Appelman Y; Radonic T; van Royen N; van Leeuwen MA; Krijnen PA; van der Wal AC; Smulders YM; Niessen HW
    J Cardiol; 2017 Jan; 69(1):394-400. PubMed ID: 27836374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis.
    Fatah K; Hamsten A; Blombäck B; Blombäck M
    Thromb Haemost; 1992 Aug; 68(2):130-5. PubMed ID: 1384157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An animal model for venous thrombosis and spontaneous pulmonary embolism.
    Frisbie JH
    Spinal Cord; 2005 Nov; 43(11):635-9. PubMed ID: 15951743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The thrombolytic effects of native tissue-type plasminogen activator (AK-124) on experimental canine coronary thrombosis.
    Tomaru T; Uchida Y; Sonoki H; Tsukamoto M; Sugimoto T
    Angiology; 1989 May; 40(5):429-35. PubMed ID: 2495745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention by DV-7028, a selective 5-HT2 receptor antagonist, of the formation of coronary thrombi in dogs.
    Morishima Y; Tanaka T; Watanabe K; Igarashi T; Yasuoka M; Shibano T
    Cardiovasc Res; 1991 Sep; 25(9):727-30. PubMed ID: 1799906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of experimental coronary thrombosis upon regional and systemic plasma chromatographic patterns.
    Chowdhury P; Moschos CB
    Thromb Diath Haemorrh; 1975 Nov; 34(2):504-12. PubMed ID: 812197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
    Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
    Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombus imaging in dogs with a monoclonal antibody (SZ-51) specific for activated human platelets.
    Wu GX; He GR; Wu JC; Ruan CG
    Chin Med J (Engl); 1992 Jul; 105(7):553-9. PubMed ID: 1280552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The predictive value of serum advanced fibrinogen and uric acid for acute coronary event risk].
    Liu MY; Hu DY
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):678-80. PubMed ID: 16681926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.
    Cowley MJ; Hastillo A; Vetrovec GW; Fisher LM; Garrett R; Hess ML
    Circulation; 1983 May; 67(5):1031-8. PubMed ID: 6831667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli.
    Sakuma T; Leong-Poi H; Fisher NG; Goodman NC; Kaul S
    J Am Soc Echocardiogr; 2003 Jan; 16(1):15-21. PubMed ID: 12514630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms.
    Lip GY; Lowe GD; Metcalfe MJ; Rumley A; Dunn FG
    Am J Cardiol; 1995 Sep; 76(7):453-8. PubMed ID: 7653443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen and homocysteine levels in coronary artery disease.
    Gheye S; Lakshmi AV; Krishna TP; Krishnaswamy K
    Indian Heart J; 1999; 51(5):499-502. PubMed ID: 10721639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.